| Title | Date | PubMed ID |
|---|
| Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparum. | 2011 Jul | 21521654 |
| Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors. | 2009 Dec | 19752273 |
| Discovery of plasmepsin inhibitors by fragment-based docking and consensus scoring. | 2009 Aug | 19472268 |
| Recombinant plasmepsin 1 from the human malaria parasite plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysis. | 2009 May 19 | 19271776 |
| Expression and enzymatic characterization of the soluble recombinant plasmepsin I from Plasmodium falciparum. | 2007 Dec | 18073224 |
| Critical roles for the digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function. | 2007 Jul | 17581121 |
| Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium falciparum. | 2007 Mar | 17207486 |
| High antiplasmodial activity of novel plasmepsins I and II inhibitors. | 2006 Dec 14 | 17149873 |
| Achiral, cheap, and potent inhibitors of Plasmepsins I, II, and IV. | 2006 Dec | 17091526 |
| Plasmepsins as potential targets for new antimalarial therapy. | 2006 Sep | 16838300 |